OTX2 rs397514463: Understanding This Rare Genetic Variant
The rs397514463 variant is a rare genetic change located within the OTX2 gene. It is associated with severe developmental eye conditions, including microphthalmia and anophthalmia, often occurring as part of a broader syndrome.
What each genotype means
Typical OTX2 gene structure
This genotype represents the common, expected sequence for the OTX2 gene in the general population. It does not contain the specific pathogenic mutation associated with syndromic microphthalmia.
This is the most common genotype found in the vast majority of the human population.
Carrier of rare variant
This genotype indicates the presence of one copy of a rare variant in the OTX2 gene. Research associates this specific change with a loss of function in the OTX2 protein, which is linked to conditions like microphthalmia and combined pituitary hormone deficiency.
This genotype is extremely rare, with an allele frequency reported at less than 0.00001 in large population databases.
Pathogenic variant present
This genotype indicates the presence of two copies of the variant, which is classified as pathogenic in clinical literature. This variant is known to disrupt OTX2 protein function, potentially leading to severe developmental conditions such as syndromic microphthalmia or anophthalmia. Individuals with this finding should consult with a clinical geneticist for professional evaluation.
This genotype is exceptionally rare and is not typically observed in general population cohorts.
What is the rs397514463 Variant?
The rs397514463 variant is a specific point mutation found within the OTX2 gene. In genetics, a point mutation occurs when a single nucleotide base is altered, which can potentially change the instructions for building a protein. This particular variant is categorized as a pathogenic loss-of-function mutation. This means the change prevents the OTX2 gene from producing a functional protein or significantly reduces its ability to perform its normal biological tasks. Because OTX2 is a transcription factor—a protein that acts like a master switch to turn other genes on or off—its disruption can have cascading effects on how tissues develop. This variant is extremely rare in the general population, and its presence is typically identified in clinical settings when investigating the underlying genetic causes of congenital structural abnormalities.
The Role of the OTX2 Gene
The OTX2 gene provides instructions for making a protein that is essential for the early development of the head, brain, and sensory organs, particularly the eyes. During embryonic development, the OTX2 protein helps regulate the timing and location of cell growth and differentiation. It is highly active in the developing retina and other ocular structures. When the OTX2 protein is absent or malfunctioning, the complex process of eye formation can be interrupted. This disruption can lead to a range of ocular malformations, including microphthalmia, where one or both eyes are abnormally small, or anophthalmia, where one or both eyes are completely absent. Because the gene is also involved in brain and pituitary gland development, mutations in OTX2 can sometimes result in syndromic conditions that affect multiple body systems, including intellectual disability or hormonal deficiencies.
Research and Clinical Evidence
Scientific research has established a strong link between OTX2 mutations and severe ocular malformations. Studies have identified these variants in families and individuals presenting with bilateral anophthalmia or severe microphthalmia. The evidence for OTX2 as a causative gene is considered high, and it is included in clinical diagnostic panels for eye development disorders. However, the clinical presentation can be highly variable, even among family members carrying the same mutation. This variability suggests that other genetic or environmental factors may influence the severity of the condition. While the association between OTX2 loss-of-function and these eye conditions is well-documented in medical literature, the specific impact of the rs397514463 variant is classified as pathogenic based on its predicted effect on protein function. As with many rare variants, ongoing research continues to refine our understanding of how these specific genetic changes translate into clinical symptoms.
Population Frequency and Interpretation
The rs397514463 variant is exceptionally rare, with a reported allele frequency in the gnomAD database of less than 0.00001. This extremely low frequency confirms that it is not a common polymorphism found in the general population but rather a rare, clinically significant mutation. Because it is so rare, it is not typically found in standard consumer genetic testing reports. If this variant is identified in a clinical context, it is usually through specialized diagnostic sequencing ordered by a medical geneticist or ophthalmologist. It is important to note that the presence of a pathogenic variant does not guarantee a specific clinical outcome due to the complexity of human development. Genetic information should always be interpreted by a qualified healthcare professional who can consider the individual's full clinical history and family context.
What You Can Do With This Information
If you or a family member have been identified as a carrier of an OTX2 variant, the most important step is to consult with a genetic counselor or a clinical geneticist. These professionals can help explain the implications of the finding, discuss the potential for inheritance, and provide guidance on appropriate medical monitoring. Because OTX2-related conditions can involve multiple systems, such as the pituitary gland or neurological development, a multidisciplinary medical team may be involved in care. It is crucial to remember that this information is for educational purposes and does not constitute a medical diagnosis. Never make changes to medical care or treatment plans based on genetic data without first speaking to your doctor. Genetic testing is a powerful tool, but it is only one piece of a much larger clinical puzzle that requires expert interpretation.
How common is this variant?
The rs397514463 variant is extremely rare, with a gnomAD allele frequency of less than 0.00001.
Frequently asked questions
What is the OTX2 gene responsible for?
The OTX2 gene provides instructions for making a protein that is critical for the development of the eyes, brain, and pituitary gland during embryonic growth.
Are OTX2 mutations inherited?
Yes, OTX2-related conditions are typically inherited in an autosomal dominant pattern, meaning a single copy of the altered gene is sufficient to cause the condition.
Can I get tested for rs397514463?
Clinical testing for specific rare variants like rs397514463 is usually performed through medical genetics clinics rather than standard consumer testing services.
What are the symptoms of OTX2-related syndromes?
Symptoms can include microphthalmia, anophthalmia, coloboma, pituitary hormone deficiencies, and potential intellectual disabilities, though severity varies significantly.
Is there a cure for OTX2-related eye conditions?
There is no genetic cure, but medical management focuses on treating the specific symptoms, such as vision support, hormonal therapy, and developmental services.
Sources & further reading
Educational information only, last refreshed 9/22/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs397514463?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in OTX2
This pathogenic missense mutation disrupts homeodomain binding, causing syndromic microphthalmia and optic nerve hypoplasia.
A well-characterized missense substitution in OTX2 causing ocular dysgenesis including coloboma, microphthalmia, and anophthalmia.